Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Equity Ratio (2022 - 2026)

HeartSciences' Equity Ratio history spans 5 years, with the latest figure at 0.35 for Q1 2026.

  • For Q1 2026, Equity Ratio rose 12.07% year-over-year to 0.35; the TTM value through Jan 2026 reached 0.35, up 12.07%, while the annual FY2025 figure was 0.05, 93.69% down from the prior year.
  • Equity Ratio reached 0.35 in Q1 2026 per HSCS's latest filing, down from 0.7 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.8 in Q1 2024 to a low of 2.9 in Q2 2022.
  • Average Equity Ratio over 5 years is 0.1, with a median of 0.33 recorded in 2025.
  • Peak YoY movement for Equity Ratio: plummeted 406.93% in 2023, then surged 1178.7% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.23 in 2022, then tumbled by 406.93% to 0.7 in 2023, then soared by 174.15% to 0.52 in 2024, then soared by 35.06% to 0.7 in 2025, then crashed by 49.67% to 0.35 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Equity Ratio are 0.35 (Q1 2026), 0.7 (Q4 2025), and 0.49 (Q3 2025).